6 Best Oncology Doctors in Qionghai

Dr. Luan Tianyan, MD, is Head of Oncology. He was recruited to Hainan Province as a high-level talent. He is a visiting scholar at the Dana-Farber Cancer Institute (USA). He is also Director of the Clinical Research Office at Bozheng Hengda International Hospital. He serves on the standing committees of the Clinical Research Management Committee (Southern Oncology Clinical Research Association), the Immunotherapy Committee (Hainan Provincial Anti-Cancer Association), and the Hainan Province Drug Research Committee.

He has more than 20 years of oncology practice. He provides individualized, comprehensive care for gastrointestinal tumors, lung cancer, and breast cancer. He focuses on pain management, palliative care, and psychological support in advanced cancer. He also works on the clinical use and study of tumor immunotherapy, including personalized mRNA vaccines and CAR-T therapy. He develops and applies proprietary drugs and related technologies.

Dr. Chen Binglai is a biological immunology expert (MD). He holds a PhD in Medicine from Central South University, with a focus on genetics and integrated TCM and Western medicine. He completed postdoctoral training at New York University and the University of Bologna. He is a visiting professor at Zhongshan Hospital, Fudan University.

He is affiliated with the Shanghai Pujiang Talent Program and the Yangpu District 3310 Talent Program. He leads the innovation project “Cancer Treatment Based on Cell Culture Technology,” supported by the Pujiang Program.

He has years of oncology practice and extensive experience in treating malignant tumors. His work focuses on the clinical use and research of CAR-T, NK cell, and stem cell therapies. He uses the Lecheng pilot program to advance clinical translation in China and to offer personalized treatment plans.

Dr. Tang Peng is Director of the Breast Cancer Center and a specialist in the International Department. He is Chief Physician and the founding Director of Breast Surgery at Hainan General Hospital and Hainan Cancer Hospital. He served as President of the 2nd Council of the Hainan Anti-Cancer Association. He was the inaugural Chair of its Breast Cancer Committee and now serves as Honorary President. His focus is early diagnosis, individualized precision therapy, and standardized care in breast cancer surgery.

His expertise includes neoadjuvant therapy, breast-conserving and oncoplastic surgery, sentinel lymph node biopsy, and minimally invasive breast surgery. He also treats benign and malignant breast disorders, including non-lactational mastitis, gynecomastia, accessory breasts, and macromastia that needs reduction. His academic roles include Committee Member of the Oncology Branch of the Chinese Medical Association, Council Member of the China Anti-Cancer Association, and Executive Committee Member of CSCO. He serves on the Executive Editorial Board of the Chinese Journal of Practical Medicine. He also holds other national and provincial posts in breast oncology.

Dr. Peng Shaohua is a Chief Physician and Professor. He is Vice President of the hospital, Director of Radiation Oncology, and a Specialist in the International Department. His practice focuses on radiotherapy and combined chemoradiotherapy for malignant tumors.

Academic appointments: Committee member of the Radiation Therapy Branch of the Chinese Medical Association and the Radiation Oncology Physicians Branch of the Chinese Medical Doctor Association. Standing committee member of the Nasopharyngeal Carcinoma Prevention and Treatment Branch of the China International Exchange and Promotive Association for Medical and HealthCare, the Special Medicine Committee of the Chinese Society of Toxicology, and the Oncology Branch of the Hainan Medical Association. Chair of the Radiation Oncology Branch of the Hainan Medical Association. He also serves on the CSCO Radiation Oncology Committee and the CSCO Nasopharyngeal Carcinoma Committee.

Research: He received the Third Prize of the Guangdong Provincial Science and Technology Progress Award. He led two provincial projects in Guangdong and three in Shaoguan. He has published over 20 academic papers.

Dr. Niu Huimin is Chief Physician and Director of the Interventional Department. He was the first in mainland China to perform Y‑90 radioembolization with both resin and glass microspheres. He is also the first physician dual‑certified on both Y‑90 systems. He serves as a national supervisor for Y‑90 therapy.

He introduced Y‑90 in 2016 and has completed hundreds of procedures. He has nearly 40 years of experience and has performed more than 50,000 interventional surgeries. He helped pioneer uterine fibroid embolization in China. He has led 22 national gynecologic interventional workshops and has received 22 science and technology awards.

His expertise includes Y‑90 for liver cancer and interventional care for gynecologic, oncologic, vascular, spinal, and urologic diseases. His research focuses on Y‑90 for liver tumors, and he has published more than 12 peer‑reviewed papers. His academic roles include Standing Director of the Hainan Cancer Prevention and Treatment Association, Chair of Hainan interventional committees, and Member of the interventional oncology committees of the Chinese Anti‑Cancer Association.

Yu Shuyong is Chief Physician and Professor and President of the hospital. He is Director of the Hainan Cancer Prevention & Treatment Center and the Cell Therapy Center, and Chair of the Hainan Anti‑Cancer Association.

He specializes in minimally invasive treatment of thyroid and gastrointestinal tumors. He pioneered radiofrequency and microwave ablation for thyroid nodules in Hainan. He has performed over 3,000 ablations with a low complication rate. He is skilled in endoscopic and laparoscopic radical surgery for gastrointestinal, esophageal, and thyroid cancers. He provides standardized and personalized care.

He serves as Vice Chair of the Oncology Committee of the China Association of Non‑Government Medical Institutions. He is an expert reviewer for the China Postdoctoral Science Foundation and an adjunct professor at Southern Medical University. He has published over 50 papers, including five in SCI‑indexed journals. He has led four Hainan‑funded projects and holds one national utility model patent. Honors include the 2025 Golden Lancet “Honored Doctors” award. He was the first surgeon in Hainan to receive it and the only awardee from a local institution in China. Other honors include Hainan Distinguished‑Contribution Expert, Provincial Outstanding Expert, the Hainan May 1st Labor Medal, and a Military Class II Special Allowance.